Geode Capital Management LLC lessened its holdings in Onconova Therapeutics, Inc. (NASDAQ:ONTX) by 93.1% during the second quarter, HoldingsChannel reports. The firm owned 142,980 shares of the biopharmaceutical companys stock after selling 1,923,647 shares during the quarter. Geode Capital Management LLCs holdings in Onconova Therapeutics were worth $990,000 at the end of the most recent 
Onconova Therapeutics Inc. (NASDAQ:ONTX) price on Friday, November 19, rose 0.64% above its previous days close as an upside momentum from buyers pushed the stocks value to $3.16. A look at the stocks price movement, the close in the last trading session was $3.14, moving within a range at $3.10 and $3.27. The beta value Is Onconova Therapeutics Inc. (NASDAQ: ONTX) A Top Momentum Pick? Read More »
Onconova Therapeutics (NASDAQ:ONTX) announced its quarterly earnings results on Thursday. The biopharmaceutical company reported ($0.22) earnings per share (EPS) for the quarter, beating the Zacks consensus estimate of ($0.33) by $0.11, MarketWatch Earnings reports. Onconova Therapeutics had a negative net margin of 8,294.27% and a negative return on equity of 74.01%. During the same period 
- Page 1 of 1.